Effect of aging on calcium signaling in C57Bl6J mouse cerebral arteries by Georgeon-Chartier, Carole et al.
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Figure S2: (A) Mean of gene expression levels quantified after RT-q-PCR in posterior cerebral arteries 
(PCA) from young (open bars) and old (hatched bars) mice. (B) Evaluation of protein expression by 
immunolabelling. Immunohistofluorescence obtained in PCA from mice and mean fluorescence in 
young (open bars) and old mice (hatched bars). Means calculated with 6 different mice for each age; 
scale bar: 5 μm.
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Figure S1: Ca2+ channels and pumps implicated in Ca2+ signalling in VSMC. GPCR (G-protein 
coupled receptors) located in plasma membrane (PM) activate transduction pathways to produce InsP3 
(via activation of phospholipase C, PLC) or cADP (via CD38 activation) evoking a Ca2+ signal by the 
binding on their receptors (InsP3R and RyR respectively). They can also activate the production of 
NAADP that binds on a specific binding protein (BP) to activate RyR and TPCN located in SR 
(sarcoplasmic reticulum) and L/E (lysosome or endosome) membranes, respectively. The voltage-gated 
Ca2+ channels (CaV1.2) activated by GPCR or depolarization evoked a Ca2+ entry responsible for the 
Ca2+-induced Ca2+ release mechanism (CICR). After activation of Ca2+ signals, the return to the basal 
level is due to the activation of SERCA and PMCA, two Ca2+ ATPases located in SR and plasma 
membrane (PM). The SR Ca2+ refilling is thus the sum of SERCA activation and store operated Ca2+ entry
(SOCE) due to Orai and TRPC channels, as well as STIM, SARAF and TRIC proteins located in PM and 
SR, respectively.
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Figure S3: (A) Means of amplitude of Ca2+
responses induced by caffeine and KCl in control 
condition and in presence of ryanodine. (B) Means
of area of cADPR-induced Ca2+ response. (C)
Means of amplitude of two successive caffeine-
evoked calcium responses separated by 60 s (left) 
and 210 s (right).  p<0,05 between young (open 
bars) and old (hatched bars) mice.  p<0,05 
between the 1st and the 2nd responses.
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Figure S6: (A) Typical NAADP-induced Ca2+
response observed in middle cerebral arteries (MCA).
(B) Means of amplitude of Ca2+ responses induced by 
NAADP. (C) Means of TPCN1 expression measured
by RT-qPCR. (D) Mean fluorescences emitted by 
immunostaining with anti-TPCN1 antibody in young
(open bars) and old (hatched bars) mice. Data are 
expressed as mean ±sem,  p < 0.05.
Figure S5: (A) Typical InsP3-induced Ca2+ response
observed in middle cerebral arteries (MCA). (B) Means of 
amplitude of Ca2+ responses induced by InsP3 photolysis
observed in young () and old mice (). (C) Means of 
expression of InsP3R subtypes measured by RT-qPCR in 
young (open bars) and old (hatched bars) mice. Data are 
expressed as mean ±sem,  p < 0.05.
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Figure S4: (A, C) Means of expression of pumps and 
channels responsible for Ca2+ signals measured by 
RT-qPCR in young (open bars) and old (hatched
bars) mice. (B) Means of fluorescence emitted by ST-
bodipy(-)-DHP in middle cerebral arteries (MCA). 
Data are expressed as mean ±sem,  p < 0.05.
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Supplementary methods
Table of primers: The efficiency, optimal Tm and dimerization of primers were tested and 
verified before qPCR experiments.
Gene of interest Primer (5’ -> 3’) Tm Accession Number
CaV1.2 For : GACGTTCCCCCAGGCTGTGTTACT
Rev : GTGATGGGGACCGAGGATAGACC
60 NM_001256002.1
RyR2 For : CATGGACAGCTTCCCCTGAA
Rev : GTGTGACTGCCGTGCTTGG
60 NM_023868.2
FKBP12.6 For: CCCCAGGAGACGGAAGGACA
Rev : GTGGGGATGATTAAATGGCTG
60 NM_016863.3
IP3R1 For : TGGCAGAGATGATCAGGGAAA
Rev : GCTCGTTCTGTTCCCCTTCAG
59 NM_010585.5 
IP3R2 For : GCTCAGATGATCACGGAGAAG
Rev : ATCTCATTTTGCTCACTGTCACCT
59 NM_010586.1
IP3R3 For : TCATTGTACTGGTCCGAGTCAAGA
Rev : GCGGGAACCAGTCCAGGT
59 NM_080553.3
SERCA2a For : TCATGGATGAGACGCTCAAG
Rev : AGGGAGCAGGAAGATTTGGT
60 NM_001110140.3
SERCA2b For : TTGGGTTTCCTGAGGCTTTA
Rev : GTCCAGGTCTGGAGGATTGA
61 NM_009722.3
SERCA3 For : TCTCGAATCGTGGAGAACCT
Rev : CCGATCTCTGCCTTCTTCAG
60 NM_016745.3
PLB For : CGAAGCCAAGGTCTCCTAAA
Rev : TAGCCGAGCGAGTGAGGTAT
60 NM_023129.5
PMCA1 For : TTAGTCTGGGAAGCATTACAAGATGTCAC
Rev : CTTCTTCCCCAACAGAAACTTCTCC
60 NM_026482.2
PMCA4 For : ACGTCTTCCCACCCAAGGTTC
Rev : CCAGCAGCCCACACTCTGTC
60 NM_213616.4
STIM1 For : GCTCTCAATGCCATGCCTTCCAAT
Rev : TCTAGGCCATGGTTCAACGCCATA
60 NM_009287.4
STIM2 For : AGGGCAACTTGACACAGACAGGAT
Rev : ATCAGGGTTGTTGGAAGTCG
60 NM_001081103.2
ORAI-1 For : TCCACGGTCATCGGGACGCT
Rev : GTCGCTGTGGTTGGCGACGA
60 NM_175423.3
TPCN1 For : ACCTCGCTCTGTCTTCCTGA
Rev : GAGGGCTTCCAGAGTTTTCC
60 NM_145853.2
TPCN2 For : ATGAAGCACAGGACCAGGAG
Rev: ATCAGGGTTGTTGGAAGTCG
60 NM_146206.4
SARAF For : CTTGAGCTAGGTGGCTTTGG
Rev : AGTAGTCGGCACTGGGCTTA
60 NM_026432.3
TRIC-A For : GTGTCCAAGGCCAGCCTCAT
Rev : CCAAACAGCACTGGGCAGAT
60 NM_144534.1
TRIC-B For : AAGGTGATGAATGGCTGAAGATGTC
Rev : ATGCTTTGAGATCGCCAGGTG
60 NM_028053.2
Immunohistofluorescence staining: Cerebral arteries were fixed during 15 minutes in 4% (g per 10-3 
L) paraformaldehyde solution in 0.1 mol.L-1 phosphate buffer (PB, pH = 7.4). Fixed arteries were 
rinsed 5 times during 10 minutes each in PB. Vessels were transferred in a saturation and 
permeabilization solution (SPS: PB containing 1% bovine serum albumin (BSA), 2% donkey serum and 
0.2% triton X100) during 60 minutes and the primary antibody (1:100, 48h, 4°C) was added. After 4 
rinses (10 minutes each) in SPS, vessels were placed in SPS containing a secondary antibody (1:200, 
2h, 22°C) for 2 hours at room temperature. Arteries were rinsed 3 times (10 minutes each) in PB. 
Samples were mounted in Fluoromount G medium and observed with SP5. All parameters of the SP5 
were kept constant to evaluate the fluorescence levels and compare the immunostaining obtained in 
arteries from yound and old animals. 
Antibodies: anti-FKBP12 (PA1-026A, Thermo Scientific, Brebieres France), anti-RyR2 (AB9080, Merck-
Millipore, Nottigham, UK), anti-STIM1 (4119, ProSci Inc, Interchim, Montluçon) were produced in 
rabbits; anti-SERCA2 (F-1, sc-376235, Santa Cruz Biotechnology, Tebu-bio, Le-Perray-en-Yvelines 
France) was produced in mice and anti TPCN1 (C-14, sc-67973) was produced in goats. Secondary 
antibodies were from FluoProbes (Interchim) and were against rabbit, mouse, and goat IgG (FP-
SA5110, FPDAMOTTGX546 and FP-DAGOTTGX488, respectively. 
